CRT* (N = 319) | EST** (N = 210) | GST*** (N = 127) | p value# | ||||
---|---|---|---|---|---|---|---|
n | (%) | n | (%) | N | (%) | ||
Gender | |||||||
Male | 147 | (46.1) | 111 | (52.9) | 61 | (48.0) | 0.31 |
Female | 172 | (53.9) | 99 | (47.1) | 66 | (52.0) | |
Age | |||||||
< 66 | 77 | (24.1) | 52 | (24.8) | 27 | (21.3) | 0.75 |
66–80 | 149 | (46.7) | 91 | (43.3) | 60 | (47.2) | 0.70 |
> 80 | 93 | (29.2) | 67 | (31.9) | 40 | (31.5) | 0.77 |
ASA score | |||||||
ASA 1–2 | 175 | (54.9) | 80 | (38.1) | 74 | (58.3) | < 0.05 |
ASA 3 | 126 | (39.5) | 92 | (43.8) | 40 | (31.5) | < 0.05 |
ASA 4 | 14 | (4.4) | 21 | (10.0) | 12 | (9.4) | < 0.05 |
Missing | 4 | (1.3) | 17 | (8.1) | 1 | (0.8) | – |
Indication for surgery | |||||||
Obstruction | 261 | (80.8) | 155 | (73.8) | 97 | (76.4) | 0.08 |
Bleeding | 13 | (4.1) | 9 | (4.3) | 4 | (3.1) | 0.87 |
Perforation | 36 | (11.3) | 29 | (13.8) | 19 | (15.0) | 0.50 |
Other | 9 | (2.8) | 17 | (8.1) | 7 | (5.5) | < 0.05 |
Tumor location | |||||||
Appendix | 4 | (1.3) | 4 | (1.9) | 3 | (2.4) | 0.68 |
Right colon | 115 | (35.1) | 84 | (40.5) | 55 | (43.3) | 0.31 |
Transverse colon | 34 | (10.7) | 17 | (8.1) | 16 | (12.6) | 0.39 |
Left colon | 166 | (52.0) | 104 | (49.5) | 53 | (41.7) | 0.14 |
pT stage | |||||||
T1–T2 | 13 | (4.1) | 6 | (2.9) | 7 | (5.5) | 0.48 |
T3 | 137 | (42.9) | 89 | (42.4) | 56 | (44.1) | 0.95 |
T4 | 167 | (52.4) | 114 | (54.3) | 64 | (50.4) | 0.78 |
TX | 2 | (0.6) | 1 | (0.5) | 0 | (0.0) | – |
pN stage | |||||||
N0 | 106 | (33.2) | 72 | (34.3) | 56 | (44.1) | 0.06 |
N1–2 | 211 | (66.1) | 136 | (64.8) | 68 | (53.5) | < 0.05 |
Missing | 2 | (0.6) | 2 | (1.0) | 3 | (2.4) | – |
M-stage¤ | |||||||
M0 | 246 | (77.1) | 164 | (78.1) | 97 | (76.4) | 0.93 |
M1 | 73 | (22.9) | 45 | (21.4) | 27 | (21.3) | 0.09 |
Missing | 0 | (0.0 | 1 | (0.5) | 3 | (2.4) | – |
Surgical specialization | |||||||
CR§ | 278 | (87.7) | 60 | (29.4) | 71 | (56.3) | < 0.05 |
Non-CR | 39 | (12.3) | 144 | (70.6) | 55 | (43.7) | < 0.05 |